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Background: Lubrication function is impaired and the lubricant content of synovial fluid (SF) changes immediately
after plateau tibia fractures. Here, we aimed to analyze the lubricant content of SF at chronic term following plateau
tibia fracture.
Methods: Forty-eight surgically treated patients without joint incongruency (<2 mm displacement) were included in
the study. Joint aspiration had been possible in 16 of the participants. However, sampling could be made from healthy
knees in only ten of these patients. Twenty-six SF samples (16 injured knees, 10 healthy knees) were analyzed for
concentrations of hyaluronic acid (HA), proteoglycan-4 (PRG4), TNF-α, IL-1β, and IL-6.
Results: The group of experimental samples were obtained at a mean of 31 (12–66) months after injury from patients
with a mean age of 45.1 (32–57) years. There were no relationships detected between biochemical analysis results and
patient ages, sexes, postoperative time, and fracture type. After excluding six patients for whom we could not sample
from their healthy knee, ten patients’ values were compared with paired Wilcoxon signed rank test and no significant
differences detected between the healthy and injured knee in terms of the SF concentrations of HA and PRG4
(p = 0.225 and 0.893, respectively). Similarly, there were no statistically significant differences in SF sample
concentrations of TNF-α, IL-1β, and IL-6 between healthy and injured knees.
Conclusions: Despite acute changes, the long-term concentrations of HA and PRG4 were similar after plateau tibial
fracture. We could not detect any concentration level differences between healthy knees and injured knees regarding
HA and PRG4 in the long-term follow-up.
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Intra-articular fractures are disabling injuries that deterior-
ate the articular surface [1, 2]. Deterioration and insuffi-
cient restoration of articular surfaces may cause arthrosis
and secondary labor loss [2].
Apart from the articular surface integrity, an ideal lubri-
cation provides reduction of friction and wear of the car-
tilage surface. This mechanism is directly related to
lubricant content of synovial fluid (SF) with hyaluronic
acid (HA) and proteoglycan-4 (PRG4) [3]. Lubrication
activity of SF is critical because even small increases in
friction may result in disruption of joint surfaces [4]. HA
and PRG4 are the primary lubricant macromolecules in SF
[5], with HA being the quantitatively major component.* Correspondence: drmehmeterdil@gmail.com
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known lubricant agent capable of reducing joint friction.
After intra-articular traumas, such as anterior cruciate
ligament (ACL) injury and plateau tibia fractures, it is
known that lubrication function is impaired, for
example, PRG4 lubricant content decreases and degen-
erative enzymes and inflammatory marker levels increase
[6]. In this way, cartilage destruction develops, and ar-
throsis starts. Similarly, after acute ACL injuries, the
amount of lubricant is decreased in various animal
models [7–9].
Here, we aimed to analyze the lubricant content of SF
of patients who had a minimum of 12 months follow-up
after being surgically treated for plateau tibia fracture.rticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 1 Synovial fluid. Gross appearance of collected human synovial
fluid from both knees of a patient
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After local ethics committee approval (Bezmialem Vakif
University Ethical Committee of Clinical Trials, approval
no: B.30.2.BAV.0.05.05/518), the retrospective records of
126 tibia plateau fracture patients were analyzed. The
patients, who had closed fractures and that had been sur-
gically treated with a minimum follow-up of 12 months,
were included in our study. All of the subjects were
informed about our study and provided informed consent.
All steps of the study were carried out in compliance with
the Helsinki Declaration.
The data were analyzed using SPSS 11.5 (Statistical
Package for Social Sciences) software. The student’s t test
was utilized to examine statistical differences between
injured and non-injured knee samples with significance
reported at the 95 % confidence levels.
Patient selection
Of the 126 patients, only 69 matched the inclusion cri-
teria, with minimum follow-up of 12 months and surgi-
cally treated closed plateau tibia fracture. Twenty-one
patients did not accept to participate in the study.
First, patients were examined by two clinicians to
ensure that there was no acute injury condition. This
study was primarily limited to those patients who had
no history of receiving intra-articular injections prior to
study and no recent joint traumas within 6 months.
Seventeen patients were excluded because they matched
one or more of the following: previous trauma to the
non-injured knee; joint incongruity >2 mm in their post-
operative computerized tomography (CT) scans; oral
chondroprotective agent usage; history of previous knee
infection; history of previous knee arthroscopy; with
known viral diseases (HIV, Hepatitis B, and C) which
may effect the serological results; and patients unable to
provide consent. The remaining 31 patients composed
the study group.
Radiological examination
In accordance with ethics committee consent, CT scans
were performed and the step-in joint surface was noted.
Tibial articular surface displacement was measured digit-
ally on CT images by two orthopedic surgeons by a
digital imaging system (Centricity PACS, GE Healthcare,
Pittsburg, PA). Fracture types were recorded according
to the initial plain radiographs. Patients with joint incon-
gruity >2 mm were excluded from the study.
Synovial fluid sampling
The remaining 31 patients were scheduled for synovial
sampling. All of our patients were sampled from both
their injured and healthy knee. After preparation of a
sterile sampling setting, a standard 20-gauge needle at-
tached to a 10-cc syringe barrel was introduced into thejoint and a minimum of 2 cc SFs was aspirated. Patients
that could not be sampled from their injured knee were
excluded from the study. Joint aspirations were success-
ful in 16 patients, and these patients make up the study
group. However, sampling could be performed from the
healthy knee in only 10 of these 16 patients.
Gross and biochemical analysis of human synovial fluid
samples
Any specific color change or opacity was not preferred
for quality measurements. Therefore, SF samples were
centrifuged (3000 g for 30 min at 4 °C) to obtain separate
fractions (Figs. 1 and 2). Following centrifugation, the
supernatants were separated and aliquots stored at −80 °C
until analysis.
Twenty-six SF samples were analyzed biochemically for
concentrations of HA, PRG4, tumor necrosis factor-α
(TNF-α), interleukin-1β (IL-1β), and interleukin-1 (IL-6).
A minimum number of two replicate samples per speci-
men were used for concentration measurements. The
concentration of HA, TNF-α, IL-1β, and IL-6 in SF sam-
ples were determined by an enzyme-linked immunosorb-
ent assay (ELISA)-like assay, and the PRG4 levels were
determined by Western blot technique.
Hyaluronan analysis
The concentrations of HA molecules in SF were deter-
mined by an ELISA-like assay, according to protocols
provided by manufacturers (Hyaluronan ELISA kit, RD
systems, Minneapolis, MN). The results were expressed
in milligram/milliliter.
PRG4 analysis
The concentration of PRG4 in SF samples was quanti-
fied by Western blot with the use of an antibody to
lubricin after SDS-horizontal agarose gel electrophoresis
Fig. 2 Before analysis. After centrifugation, the supernatant fluid
including synovial content, and the bottom layer is the cell pellet of
the sample
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nylidene fluoride membrane. The immunoreactive pro-
teins were detected by Amersham ECL Plus detection
and digital scanning with a STORM 840 imaging system
(GE Healthcare, Piscataway, New Jersey). ImageQuant
(GE Healthcare) was used to generate densitometric
scans. Like the previous studies, PRG4 was quantified
with the use of purified explants and run on the same
gels [10, 11]. The results were expressed in microgram/
milliliter.TNF-α, IL-1β, and human IL-6 analysis
The concentrations of human TNF-α, IL-1β, and human
IL-6 in SF were calculated using ELISA kits, according
to protocols provided by manufacturers (Human TNF-α
Platinum, Human IL-1β Platinum, and Human IL-6
ELISA kits, MedSystems, Vienna, Austria). The results
were expressed in pg/mL.Results
A total of 26 fluid samples collected from 16 patients
were used in this study. No other samples of control SF
were used outside of the study group. Four of the pa-
tients were male and 12 were female. Mean age was 45.1Table 1 Analysis of inflammatory cytokines
TNFalpha-h (pg/ml) TNFalpha-i (pg/ml) IL1B
Min. 54.56884484 51.59461292 9.3
Max. 59.08147257 59.95323021 9.9
Mean all 56.48671162 56.37004994 9.7
SD all 1.882955702 2.537548259 0.2
Mean-paired 56.48671162 56.55850343 9.7
SD-paired 1.882955702 3.061669654 0.2
The minimum (Min.), maximum (Max.), and mean and standard deviation (SD) values o(32–57) years, and the mean follow-up period was 31
(12–66) months.
In preoperative examinations of digital recordings,
three patients were found to have had: type 2, four pa-
tients; type 3, two patients; type 4, three patients; type 5,
four patients; and type 6 tibia plateau fracture according
to the Schatzker classification. In all patients, surgical
treatment was acceptable (under 2-mm step-off ) with
restoration of the articular surface. The injured joint sur-
faces were collapsed by a mean of 0.39 mm (min. 0.13,
max. 0.65, SD: 0.19), as detected by CT analysis on the
day of SF sampling. In the analysis of Spearman’s non-
parametric test, there was no significant correlation be-
tween the results of the biochemical analysis, fracture
type, and displacement of articular surface (p > 0.05).
In biochemical analyzes of HA, TNF-α, interleukin-1B,
interleukin-6, and PRG4 levels were compared with the
amount of displacement of fractures that were evaluated
with CT analyses, age, sex, and postoperative time. Using
the Spearman’s correlation test, we detected no relation-
ships between biochemical analysis results and patient
ages, sexes, postoperative time, or Schatzker type param-
eters. There were no statistically significant differences
between these parameters (p > 0.05).
After excluding six patients for whom we were unable
to sample from their healthy knee, ten patients’ values
were compared using the paired Wilcoxon signed rank
test. There were no significant differences between the
healthy and injured knee in terms of the composition
of SF (p > 0.05). In this group, the average HA concen-
trations for the injured knee was 0.843 mg/mL (min.
0.78, max. 0.9, SD = 0.458) compared to 0.901 mg/mL
for the injured knee (min. 0.829, max. 0.961, SD = 0.48,
p = 0.225). The injured knee PRG4 average was
58.94 μg/mL (min. 50.7, max. 70, SD = 7.12), while the
healthy knee PRG4 average was 58.82 μg/mL (min.
52.2, max. 69, SD = 6.35, p = 0893). Similar to above,
there were no statistically significant differences in SF sam-
ple concentrations of TNF-α (p = 0.686), IL-1β (p = 0.225),
and IL-6 (p = 0.225) between healthy and injured knees
(Table 1).
After the comparison of SF analysis results, no statisti-
cally significant differences were observed in SF sample-h (pg/ml) IL1B-i (pg/ml) IL6-h (pg/ml) IL6-i (pg/ml)
96551724 9.123152709 18.79310345 18.24630542
43349754 19.408867 19.88669951 38.81773399
22660099 11.94488916 19.4453202 23.88977833
08957888 4.501883044 0.417915774 9.003766086
22660099 9.594581281 19.4453202 19.18916256
08957888 0.091707019 0.417915774 0.183414039
f inflammatory cytokines in synovial fluid samples (h, healthy and i, injured knees)
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between healthy and injured knees. The mean HA level
of all injured knees was identified as 0.841 mg/mL (min.
0.78, max 0.9, SD = 0.354). When these results were
compared with the mean level of HA that was obtained
from healthy knees, there was no significant difference
(p = 0.225). Similarly, there was no significant difference
between the mean level of PRG4 (59.51 μg/mL, min.
50.7, max. 70, SD = 5.84) taken from all injured knees and
the mean level of PRG4 in healthy knees. In addition,
there was no significant difference in inflammatory cyto-
kine levels between healthy and injured knees (p > 0.05).
Discussion
Tibial plateau fractures are intra-articular fractures that
may lead to arthritis due to disruption of the articular
cartilage through primary impact or inaccurate reduc-
tion of fracture. In addition, lubrication in the joint may
be disturbed due to the change of SF characteristics. In
this study, we attempted to analyze the concentrations
of HA and PRG4 in patients who had been treated due
to tibial plateau fractures and had higher risk for arthro-
sis in the long term.
Here, we report HA concentrations in the SF of healthy
donors of between 1.8 and 3.33 mg/mL [11–14]. This
compares with the slightly higher previously reported SF
HA concentrations between 3.2 and 4.1 mg/mL [5]. There
is as yet no consensus regarding the change in HA levels
of SF under pathologic conditions, such as in osteoarth-
ritis (OA) and intra-articular fractures, although some
authors have reported normal levels of HA in arthritic
joints [13, 15]. Ludwig et al. measured the SF HA concen-
trations of normal and osteoarthritic knees as 0.11 to 0.96
and 0.23 to 2.69 mg/mL, respectively [12]. The SF HA
concentration in OA patients was reported as between 1.2
and 2.2 mg/mL [5]. According to one study, intra-articular
fractures cause a decrease in HA levels in SF [11, 16].
Ballard et al. reported the mean HA levels of injured knees
as 0.27 mg/mL [11]. Here, we detected the HA concentra-
tion of SF HA in healthy and injured knees as 0.841 and
0.901 mg/mL, respectively (p = 0.225), which are compar-
able with those reported in the literature. Although some
parameters (e.g., age, sex, trauma severity, and assay sensi-
tivity) may affect these analyses [11], the concentration of
HA in these samples did not differ between healthy and
injured knees.
A deficiency in PRG4 proteins (also known as lubricin,
superficial zone protein, and megakaryocyte-stimulating
factor [10, 17]) is an important issue because it is known
to increase friction at the joint surface [4, 11]. The re-
ported PRG4 concentration in the SF of humans varies
between 52 and 350 μg/mL postmortem and 276 to
762 μg/mL in SF obtained during arthrocentesis [11].
Ludwig et al. detected the PRG4 levels in normal SF asbeing between the ranges of 129 and 450 μg/mL [12].
There is a large variability in the measured PRG4 levels
of SF from patients with joint disease [11, 12]. Changes
in PRG4 concentration after acute injury have been pre-
viously noted [6, 11, 12, 18];, however, conflicting result
regarding this have also been produced [6, 18]. In an
animal study, the PRG4 concentration of SF decreased
from 280 to a 20 to 100 μg/mL range at 3 weeks after
injury [19]. These decreased PRG4 levels returned to
normal values within 1 year of ACL injury [6]. Yet other
studies have reported increased PRG4 concentrations
after intra-articular fracture and OA patients [11, 18].
Additionally, in another study, increased PRG4 concen-
trations were found to be correlated with the severity of
OA [18]. These differences may be related to the study
design, biochemical assay, and objective selection criteria
[11]. In our study, all of the samples were taken from
the same patient population (i.e., both injured and
healthy joints were exemplified with same biochemical
assay). The mean PRG4 concentrations were 59.51 μg/mL
in injured knees and 58.82 μg/mL (p = 0.893) in healthy
knees, according to our analyses. This similarity in the
mean levels of the injured and healthy knees espoused the
hypothesis that PRG4 levels return to normal in the long-
term analyses [6].
A previous animal study demonstrated that increased
intra-articular fracture severity increases acute joint path-
ology, including synovial inflammation [20]. Furthermore,
pro-inflammatory cytokines such as IL-1, IL-6, and TNF-α
were upregulated in injured and degenerative joints [21,
22]. SF levels of IL-1β and TNF-α were measured by
ELISA to exclude the effects of the acute injury, which
may affect the results. The presence of inflammatory cyto-
kines (IL-1β, TNF-α) in the SF samples was quantified by
commercially available kits. To exclude the effects of new
trauma and inflammation, which may affect the PRG4
levels, we controlled the IL-1β and IL-6 levels [6].
SF is a combination of HA, PRG4, and surface active
phospholipids (SAPL); each of these molecules interact for
boundary lubrication function of SF [23]. Although HA
and PRG4 are the primary lubricant macromolecules, con-
flicting results regarding their normal concentrations have
been reported [5]. We identified no difference in the HA
and PRG4 concentrations of healthy and injured knees.
Although we could not make a mechanical test for friction
change, we think that lubrication change may be due to
another factors like unknown molecules other than HA or
PRG4.
Ballard et al. reported that knees afflicted with a tibia
plateau fracture have SF with decreased lubrication
properties, as well as decreased concentrations of HA
[11]. In Ballard et al.’s study, the samples were taken
during the fracture operation and no long-term or time
dependent changes were taken into consideration [11].
Ceylan et al. Journal of Orthopaedic Surgery and Research  (2015) 10:89 Page 5 of 6Instead, they showed the correlation between lower HA
and lower lubrication properties of pathological SF;
however, this condition appears to recover after 1 year.
These findings are in line with the results reported
here.
Ross et al. reported a comparative study on injured
and uninjured knees [24], which included 52 patients,
but the study group was not homogenous and included
both acute and previous trauma cases. Aspirations from
injured and non-injured knees were equally successful in
all cases. They used ten healthy athletes from among the
injured sampling group as a reference group. We propose
that this might have led to a bias in their study. In our
study, all of the samples were taken from the same patient
population (i.e., both injured and healthy joints were ex-
emplified with same biochemical assay).
It has been reported that, in the case of acute trauma,
increased loss through the inflamed synovium may ac-
count for the low levels of PRG4 [5, 25]. However, in
the study of Ballard et al. the results were controversial,
with the HA levels also being lower. This decrease in
HA concentration may be due to SF dilution caused by
traumatic edema. Further studies are needed to eluci-
date these issues.
The results of our study indicated that the chronic
term concentrations of HA and PRG4 in SF are similar
after plateau tibial fracture. Various studies have re-
ported results contrary to this finding [5, 6, 11, 12, 18,
19]. We used the uninjured knees of patients to check
for the presence of active inflammation by IL-1β, IL-6,
and TNF-α and confirmed the absence of current
trauma, which may have affect the results. We could not
find any concentration level differences between healthy
knees and injured knees regarding HA and PRG4 within
a minimum of 1 year follow-up. Furthermore, the me-
diators (IL-1β and IL-6) related to arthrosis were not
quantitatively higher in fractured knees.
Our study has some limitations. First, the sample size
was limited due to some patients not consenting to
participate to our study and other restrictions due to
inclusion criteria. We were therefore unable to make a
subgroup evaluation of this patient group due to lim-
ited sample size. We would also obtain more objective
results if we could make the same analysis for these pa-
tients in the acute and chronic term. On the other
hand, a power analysis was not performed before the
study. A prospective study, with a prior power analysis
may give more relevant information in this topic. Also,
sampling of the highly viscous SF is difficult; in six
patients, we were unable to aspirate SF from their
healthy knees. Additionally, there might be increased
stress on the contralateral knee in patients with injury
that could alter the synovial fluid and the HA and
PRG4 results may be affected. Another limitation is thatwe were unable to make a molecular weight analysis of
HA samples. In addition, we were unable to make a lubri-
cation analysis due to financial and technical impair-
ments. Synovial proteins (e.g., COMP and lubricin) that
may affect lubrication were not analyzed [10, 17]. Sys-
temic levels of HA and inflammatory cytokines, that
have been shown to predict disease outcome, were also
not analyzed [26, 27]. We sampled the healthy knee of
each patient. But the unaffected knee may be overly
stressed due to the fact that the patient had an injury
on the contralateral side and, therefore, would not be
completely normal due to the increased stress from
compensating for problems on the contralateral side.
The concentrations of each protein may change at vari-
ous moments after an injury; repetitive analyses may
help detailed analysis of this problem. More detailed
studies are required to better demonstrate the accurate
changes in SF composition.
Conclusions
Knee homeostasis seems to be restored in terms of the
synovial fluid 1 year following a traumatic event. Fur-
ther prospective studies that combine the biochemical
and biomechanical analyses of SF may be helpful in
clarifying these issues in the chronic posttraumatic
period.
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